Variables | CONTROL (n = 37) | EXPERIMENTAL (n = 35) | PLACEBO (n = 37) | p-value | |
---|---|---|---|---|---|
Gender | Men | 32.3% (21) | 38.5% (25) | 29.2% (19) | 0.201 |
Women | 36.4% (16) | 22.7% (10) | 40.9% (18) | ||
Age | 66.27 (10.55) | 64.86 (12.14) | 65.62 (10.93) | 0.867 | |
PRI Total | Initial (Post Qx) | 30.59 (8.96) | 25.71 (12.42) | 26.92 (11.12) | 0.143 |
Final | 28.35 (7.61)*♣ | 11.69 (7.53)* | 22.86 (9.33)*♣ | <0.001 | |
FVC | Initial (Post Qx) | 51,81 (11.14)♣ | 56.66 (8.54) | 59.83 (11.14)♣ | 0.005 |
Final | 59.68 (9.72)* | 83.77 (14.04)* | 69.11 (12.07)* | <0.001 | |
FEV1 | Initial (Post Qx) | 55.00 (11.12)♣ | 58.37 (9.72) | 63.54 (14.14)♣ | <0.01 |
Final | 61.54 (9.56)*♦ | 87.06 (13.41)* | 71.46 (11.40)*♦ | <0.001 |